Helen Heslop
Baylor College of Medicine
H-index: 112
North America-United States
Top articles of Helen Heslop
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Calcineurin Inhibitor-Free Graft-Versus-Host Disease (GVHD) Prophylaxis in Hematopoietic Cell Transplantation (HCT) with Myeloablative Conditioning Regimens (MAC) and HLA … | Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy | Marcelo C Pasquini Robert Soiffer Brent Logan Manmeet Kaur Steven M Devine | 2024/2/1 |
Incipient clonal hematopoiesis is accelerated following CD30. CAR-T therapy | Cytotherapy | Chiraag D Kapadia Gerardo Rosas Sachin G Thakkar Mengfen Wu Virginia Torrano | 2024/3/1 |
Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma | Helen Heslop Che-Hsing Li Sandhya Sharma Andras Heczey David Steffin | 2024/4/11 | |
A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help | Blood Advances | Kevin J Curran Sarah Nikiforow Carlos Bachier Yen-Michael Hsu David Maloney | 2024/2/27 |
Off-the-Shelf CD19-Specific CAR-NKT Cells in Patients with Relapsed or Refractory B-Cell Malignancies | Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy | Carlos A Ramos Amy N Courtney Premal D Lulla LaQuisa Chimere Hill Rammurti T Kamble | 2024/2/1 |
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers | Andras Heczey David Steffin Nisha Ghatwai Antonino Montalbano Purva Rathi | 2024/4/3 | |
Reduced Cumulative Dosing of Alemtuzumab in Patients with Hemophagocytic Lymphohistiocytosis (HLH) Is Associated with Improved Long Term Survival | Transplantation and Cellular Therapy | David HM Steffin Daria Vakula Khaled Yassine Erin Morales Anil George | 2024/2/1 |
Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia | Transplantation and Cellular Therapy | Gabriela Llaurador Kristen Shaver Mengfen Wu Tao Wang Amanda Gillispie | 2024/2/1 |
Antitumor efficacy and safety of unedited autologous CD5. CAR T cells in relapsed/refractory mature T-cell lymphomas | Blood | LaQuisa C Hill Rayne H Rouce Mengfen J Wu Tao Wang Royce Ma | 2024/3/28 |
Analyzing the Effects of Obesity and Ethnicity on Outcomes of Pediatric Patients with Hematologic Malignancies Receiving Haploidentical Stem Cell Transplant with Post … | Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy | Erin E Doherty Kristen Shaver John Craddock Baheyeldin Salem Anil George | 2024/2/1 |
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy | Nature Medicine | Bruce L Levine Marcelo C Pasquini John E Connolly David L Porter Michael P Gustafson | 2024/1/9 |
Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosis | Cytotherapy | Feiyan Mo Chiou-Tsun Tsai Rong Zheng Chonghui Cheng Helen E Heslop | 2024/3/12 |
803: CARDIOTOXICITY OF IMMUNE EFFECTOR CELLULAR THERAPIES IN PEDIATRIC HEMATOLOGIC AND SOLID TUMORS | Critical Care Medicine | Aaron Ross Kriti Puri Nino Rainusso Shoba Navai Nabil Ahmed | 2024/1/1 |
Outcomes of Patients Underrepresented in Pivotal Trials of Anti-CD19 CAR-T Cell Therapy | Transplantation and Cellular Therapy | Daniel Goyco Vera Jonathan Lockhart George Carrum Rammurti T Kamble LaQuisa Chimere Hill | 2024/2/1 |
Long-Term Follow-Up for Recipients of Genetically Modified Cells: A Team Effort | Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy | Helen E Heslop | 2024/3/1 |
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial | Meenakshi Hegde Shoba Navai Christpher DeRenzo Sujith Joseph Khaled Sanber | 2023/1/6 | |
IMMU-15. PHASE I TRIAL OF GD2. CART-CELLS AUGMENTED WITH A CONSTITUTIVELY ACTIVE INTERLEUKIN-7 RECEPTOR (C7R) FOR TREATMENT OF HIGH-GRADE PEDIATRIC CNS TUMORS | Neuro-Oncology | Frank Lin Austin Stuckert Candise Tat Karen Moeller Mark White | 2023/6/1 |
Combining Apoptotic Resistance and Cytokine Signaling to Improve Persistence and Anti-Tumor Activity of CAR Vδ2 T Cells In Vivo | Blood | Leonard Leong Mansi Narula Helen Elisabeth Heslop Malcolm K Brenner Maksim Mamonkin | 2023/11/28 |
Introduction to a review series on banked allogeneic immune effector cells | Blood | Helen E Heslop | 2023/2/23 |
Paving the road for chimeric antigen receptor T cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force consensus on challenges and solutions to … | Transplantation and Cellular Therapy | Sarah Nikiforow Matthew J Frigault Noelle V Frey Rebecca A Gardner Krishna V Komanduri | 2023/4/1 |
Co-Authors
